Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Children's Oncology Group
Stanford University
St. Jude Children's Research Hospital
University of Wisconsin, Madison
Essen Biotech
Children's Oncology Group
University Medical Center Groningen
Karolinska University Hospital